150 related articles for article (PubMed ID: 963962)
1. [Therapeutic report on an injectable aldosterone antagonist (K-canrenoate) in states of water-salf retention].
Coltorti M; Radaeli E; Ciaccio S; Corsini R; Trebbi R
Clin Ter; 1976 Feb; 76(3):215-34. PubMed ID: 963962
[No Abstract] [Full Text] [Related]
2. [Indication and experience with an intravenously administered aldosterone-antagonist (soldactone) (author's transl)].
Kirsch R
Schweiz Rundsch Med Prax; 1975 Nov; 64(44):1414-7. PubMed ID: 1236699
[No Abstract] [Full Text] [Related]
3. [Controlled study of the effect of long-term administration of canrenoate potassium in cirrhotic ascites].
Traina M; Vizzini GB
Minerva Med; 1986 Jan; 77(3-4):87-91. PubMed ID: 3511409
[TBL] [Abstract][Full Text] [Related]
4. [Effect of spironolactone and K-canrenoate in ascitic cirrhosis. Double-blind study].
Tempini S; Bellati G; Ideo G
Minerva Dietol Gastroenterol; 1984; 30(3):255-61. PubMed ID: 6504374
[No Abstract] [Full Text] [Related]
5. [Use of canrenoate potassium given orally in ascitogenic cirrhosis].
Sarti F; Milandri GL; Piemontese A; Macchia S; Simoni S; Dal Monte PR
Minerva Dietol Gastroenterol; 1984; 30(3):273-80. PubMed ID: 6504377
[No Abstract] [Full Text] [Related]
6. [Use of potassium canrenoate in cardiosurgery].
Tufano R; Scopa M; Brando G; Leone D
Minerva Anestesiol; 1981 Apr; 47(4):149-54. PubMed ID: 7242963
[TBL] [Abstract][Full Text] [Related]
7. [Effect of canrenoate potassium on intraoperative disturbances of electrolyte equilibrium].
Eschner J; Fodor L; Ahnefeld FW
Infusionsther Klin Ernahr; 1976 Apr; 3(2):98-104. PubMed ID: 965083
[TBL] [Abstract][Full Text] [Related]
8. [Use of an aldosterone antagonist in abdominal surgery].
Ribero F; Remonda G; Morachioli N; Pugnani M
Ann Osp Maria Vittoria Torino; 1982; 25(1-6):61-70. PubMed ID: 7185311
[TBL] [Abstract][Full Text] [Related]
9. [The use of an injectable anti-aldosteron agent in the treatment of secondary hyperaldosteronism].
Tartagni F; Ambrosioni E
Boll Soc Ital Cardiol; 1976; 21(4):725-7. PubMed ID: 1031037
[No Abstract] [Full Text] [Related]
10. [Potassium canreonate in neurosurgical brain edema].
Mille T; Rodriguez R; Baena Y
Minerva Chir; 1975 Jul 15-31; 30(13-14):781-9. PubMed ID: 1221307
[TBL] [Abstract][Full Text] [Related]
11. [Therapeutic effect of canrenoate potassium (soldactone) in patients after open-heart surgery].
Matsuda K; Tatsuta N; Konishi Y; Minami K; Nishiwaki N; Yamasato A; Chiba Y; Ishihara H; Murata S; Shiraishi Y; Muraguchi T; Hikasa Y
Nihon Geka Hokan; 1982 May; 51(3):519-27. PubMed ID: 7138201
[No Abstract] [Full Text] [Related]
12. [Clinical experience with the use of a new drug: "ethacrynic acid"].
Cicconetti C; Cantera N
Policlinico Prat; 1969 Jan; 76(3):69-78. PubMed ID: 5763598
[No Abstract] [Full Text] [Related]
13. [Brain edema in neurosurgery. Trial with an aldosterone-antagonist (soldactone) (author's transl)].
Anderes JP; de Tribolet N; Zander E
Schweiz Rundsch Med Prax; 1977 Aug; 66(32):1020-6. PubMed ID: 556440
[No Abstract] [Full Text] [Related]
14. High doses of spironolactone (Aldactone, SC-14266, Verospirone) alone and in combination with triamterene and-or diuretics in the treatment of refractory edema associated with secondary hyperaldosteronism.
Radó JP; Marosi J; Takó J
Endokrinologie; 1970; 57(1):46-62. PubMed ID: 4923990
[No Abstract] [Full Text] [Related]
15. [Disorders of water and electrolyte equilibrium in liver diseases. Part 3: therapy (author's transl)].
Kuntz E
MMW Munch Med Wochenschr; 1982 May; 124(19):465-7. PubMed ID: 6810108
[No Abstract] [Full Text] [Related]
16. [Plasma hyperosmolarity aspects in intensive care and its treatment with potassium canreonate].
Ruggerini R; Mazzocchi F; Albini G; Cifalinò M
Minerva Anestesiol; 1979 Sep; 45(9):687-90. PubMed ID: 117400
[TBL] [Abstract][Full Text] [Related]
17. [Clinical experience in the use of Osyrol 100 and Osyrol for injection (author's transl)].
Gorbach HC; Bräuninger HJ
MMW Munch Med Wochenschr; 1975 Sep; 117(37):1483-6. PubMed ID: 810673
[TBL] [Abstract][Full Text] [Related]
18. Comparative clinical study of spironolactone and potassium canrenoate. A randomized evaluation with double cross-over.
Emili M; Cuppone R; Ricci GL
Arzneimittelforschung; 1988 Oct; 38(10):1492-5. PubMed ID: 3058132
[TBL] [Abstract][Full Text] [Related]
19. [Clinical trials of ethacrynic acid].
Laroche C; Grégoire J
Sem Hop; 1967 Jun; 43(28):1845-50. PubMed ID: 4294301
[No Abstract] [Full Text] [Related]
20. [Effectiveness of K canrenoate in the treatment of secondary hyperaldosteronism].
Tartagni F; Pasetti L; Ambrosioni E; Magnani B
G Clin Med; 1979 Mar; 60(3):196-206. PubMed ID: 520727
[No Abstract] [Full Text] [Related]
[Next] [New Search]
